ERBB2 and breast carcinoma: Also, while performing the survival analysis of breast cancer, models revealed elevated hazard ratios for the HER2-enriched and LumB subtypes, suggesting poorer survival relative to the reference group, and LumA exhibited a trend toward better survival outcomes.